Definium Therapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
DFTX Nasdaq 2830 definiumtx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Definium Therapeutics, Inc.

Jefferies Highlights Three Biotech Stocks With Blockbuster Potential - Sep 30th, 2026 1:32 pm
Definium Therapeutics Announces New Employee Inducement Grants - Sep 28th, 2026 2:01 pm
Definium Therapeutics Highlights Phase III DT120 Gains in Anxiety and Depression - Sep 24th, 2026 12:02 am
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - Sep 21st, 2026 9:01 am
Definium’s LSD Pill Clears a Second Anxiety Trial, and the Psychedelics Sector Is Watching - Sep 20th, 2026 10:28 am
Definium Therapeutics’ DT120 Hits Phase III Goals in Anxiety Study - Sep 19th, 2026 5:02 pm
Biotech Midweek Pulse: XBI Loses Steam After Hot 2026 Run — Here Are The Stocks And Catalysts To Watch Next - Sep 15th, 2026 7:51 pm
Definium Reports Second Phase III Success in Anxiety Disorder Program - Sep 15th, 2026 8:16 am
Definium Therapeutics (DFTX) Stock May Trade At A Premium Despite Phase 3 DT120 Results - Sep 15th, 2026 7:12 am
Definium tees up regulatory submission for psychedelic on Phase III hat trick - Sep 15th, 2026 5:04 am
Why Definium Therapeutics (DFTX) Is Up 5.7% After Second Positive Phase 3 DT120 Anxiety Trial Result - Sep 15th, 2026 3:12 am
Definium Therapeutics (DFTX) After Its Phase 3 Win Still Looks Undervalued - Sep 15th, 2026 2:11 am
The Psychedelics News That Sent Definium, Already Up 190% This Year, Soaring - Sep 14th, 2026 2:10 pm
Psychedelics Are Wall Street’s Next Trip. Why This Biotech Stock Is Already Up 200%. - Sep 14th, 2026 1:09 pm
Sector Update: Healthcare Stocks Rise in Afternoon Trading - Sep 14th, 2026 11:49 am
DFTX Stock Climbs As High As 12% On ‘Unprecedented’ Anxiety Data For LSD-Based Drug - Sep 14th, 2026 11:17 am
Definium Therapeutics Shares Rise 20% After Phase 3 Anxiety Trial Meets Primary Endpoint - Sep 14th, 2026 7:30 am
Definium Therapeutics Announces Positive Topline Results from Phase 3 Panorama Study of DT120 ODT in Generalized Anxiety Disorder - Sep 14th, 2026 5:00 am